Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Uruguay gives pharmacies green light to start selling marijuana
Uruguay's three-year process of legalizing recreational cannabis consumption reached its final stage on Thursday, when the government said it would authorize pharmacies to begin selling the substa...
FDA approves Cipla’s HIV-1 generic
MUMBAI, India — Cipla received Food and Drug Administration approval for its Abbreviated New Drug Application for Abacavir and Lamivudine Tablets USP, 600 mg/300 mg, from the Abacavir and Lamivudine...
Tumor necrosis factor may help control blood pressure, study suggests
Investigators at the Ted Rogers Centre for Heart Research have discovered a surprising new role for tumor necrosis factor (TNF).
Takeda gains exclusive global rights to gastroenterology candidate
Japanese drugmaker Takeda Pharmaceutical (TYO.
FDA approves drugs more quickly than peer agency in Europe: study
The U.
Combination of Optune™ with Standard of Care Chemotherapy, Temozolomide, Provides Landmark Five-Year Survival Rates for Newly Diagnosed Glioblastoma Patients
ST.
Canadian biopharma company Zymeworks files for U.S. IPO
Canadian biopharmaceutical company Zymeworks said it has filed with the U.
Scientists find common antibiotic could prevent or treat PTSD
LONDON - A common antibiotic called doxycycline can disrupt the formation of negative thoughts and fears in the brain and may prove useful in treating or preventing post-traumatic stress disorder (...
Maple syrup extract may dramatically increase the potency of antibiotics
Toronto.
Teva Announces FDA Approval of AUSTEDO™ (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease
JERUSALEM--(BUSINESS WIRE)--Apr.
Paratek Announces Positive Phase 3 Study of Omadacycline in Community-Acquired Bacterial Pneumonia
BOSTON, April 03, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc.
Low-dose aspirin can reduce risk of death from cancer, research says
An aspirin a day may keep the doctor away.
546
547
548
549
550
551
552
553
554
